| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.4B | $0.3B | $0.3B | $0.4B | $0.3B | $0.1B | $0.3B | $0.4B |
| EPS (Basic) | $1.26 | $1.12 | $1.01 | $1.18 | $0.91 | $0.08 | $0.21 | $0.26 |
| EPS (Diluted) | $1.25 | $1.11 | $1.01 | $1.17 | $0.90 | $0.08 | $0.21 | $0.26 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.1B | $8.9B | $8.3B | $8.4B | $8.4B | $8.3B | $8.1B | $8.2B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.3B | $0.4B | $0.0B | $0.0B | $0.3B | $0.4B | $0.0B | $0.0B |
| Total Liabilities | $6.1B | $5.9B | $5.5B | $5.6B | $5.7B | $5.7B | $5.4B | $5.4B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $3.0B | $3.0B | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $0.6B | $0.6B | $0.6B | $0.6B | $0.4B | $0.5B | $0.5B |
| Investing Cash Flow | $-0.5B | $-0.4B | $-0.2B | $-0.5B | $-0.3B | $-0.2B | $-0.2B | $0.7B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.2B | $0.2B | $-0.4B | $-0.4B | $-0.3B | $0.1B | $-0.4B | $-1.3B |